Eugene Durenard - 08 Jan 2022 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role: Director
Signature: /s/ Eugene Durenard
Issuer symbol: CODX
Transactions as of: 08 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Jan 2022, 16:05:13 UTC
Previous filing: 22 Sep 2021
Next filing: 12 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CODX	Common Stock	Award	$0	+12,500		$0.000000	12,500	08 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CODX	Restricted Stock Units	Options Exercise	$0	-12,500	-50%	$0.000000	12,500	08 Jan 2022	Common Stock	25,000	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021.